Trefoil Peptides in Lung Diseases

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00839735

Enrollment

Registered

2009-02-09

Start date

2009-02-28

Completion date

2010-05-31

Last updated

2021-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Chronic Obstructive Pulmonary Disease

Keywords

COPD

Brief summary

The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Age 18 years or older * Informed consent

Exclusion criteria

* Upper and lower airway infection 2 weeks prior to visit 1

Design outcomes

Primary

Measure	Time frame
TFF in sputum	Monthly

Countries

Denmark

Outcome results